Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Low Radiation Doses in Nature May Pose Risk

By Biotechdaily staff writers
Posted on 20 May 2002
A study has found that radiation can trigger widespread mutations in living cells at much lower doses than previously thought possible. More...
Conducted by researchers at Columbia University College of Physicians and Surgeons (New York, NY, USA), the study was published in the December 4, 2001, issue of the Proceedings of the National Academy of Sciences.

The study found that a dose that strikes as few as one in 10 cells has nearly the same mutagenic effect as a dose that strikes every cell. The added damage occurs because of what is called the "bystander effect,” in which injured cells send aberrant signals to neighboring cells. This effect occurs with alpha particles, which come from such sources as nuclear explosions, plutonium, and radon, a naturally occurring gas that seeps into many homes.

The risks of exposure to lower radiation levels are poorly understood and have been the subject of controversy for decades, say the researchers. In the study, they found that when they beamed alpha particles at only one in 10 cells, the results were almost the same as if they had beamed them at all cells. Nearly all the cells showed mutations in their DNA. However, the researchers found they could prevent widespread damage by blocking the signaling network that exists between cells. By using chemicals that obstruct key cell-to-cell pathways, the researchers could restrict the damage to the 10% of cells that had directly received alpha particles. This suggests that signaling networks are responsible for spreading the damage, but little is known about the signaling mechanism at this time.

Previously, public health officials have assumed the risk of radiation is proportional to the dose. Lower doses carry lower risk. The new findings suggest such a linear relationship might not be operating. Instead, the study suggests that at low doses, the risk rises steeply in proportion to the dose, while at higher doses, the risk rises more gently in relation to the dose.

According to Dr. Howard L. Liber, associate professor of radiobiology at Harvard School of Public Health, the study is "another piece of hard evidence to suggest we may need to reassess acceptable radiation levels.”


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Automatic Hematology Analyzer
CF9600
Automated Clinical Chemistry Analyzer
Envoy 500+
New
Microbiology Laboratory Automation Solution
BD Kiestra™ ReadA+BarcodA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Alzheimer’s pathology can start 15 to 20 years before symptoms, and validated tools that reach patients earlier help pave the way for earlier detection. (Image Credit: Adobe Stock)

Alzheimer’s Blood Test Becomes First FDA-Cleared Option for Adults as Young as 40

C2N Diagnostics’ PrecivityAD2 blood test was cleared by the U.S. Food and Drug Administration (FDA) on August 20, 2026, for adults as young as 40 who are experiencing signs of cognitive impairment, according... Read more

Pathology

view channel
Image: Adrenal gland tumor stained with hematoxylin and eosin (top) and CYP11B2 (bottom) (Photo courtesy of Christofer Juhlin)

Simple Immunohistochemical Size Ratio Improves Classification of Primary Aldosteronism

Primary aldosteronism is a common but underdiagnosed cause of hypertension, in which excess aldosterone promotes salt retention and raises blood pressure. Identifying the dominant source of hormone overproduction... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.